RNA-modifying proteins as anticancer drug targets
Crossref DOI link: https://doi.org/10.1038/nrd.2018.71
Published Online: 2018-05-18
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boriack-Sjodin, P. Ann
Ribich, Scott
Copeland, Robert A.
Text and Data Mining valid from 2018-05-18
Version of Record valid from 2018-05-18
Article History
First Online: 18 May 2018
Competing interests
: The authors are all employees and stockholders of Accent Therapeutics.